Certuity’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,685
Closed -$252K 275
2023
Q2
$252K Sell
2,685
-361
-12% -$28.2K 0.03% 224
2023
Q1
$207K Buy
+3,046
New +$196K 0.03% 203
2022
Q2
Sell
-3,196
Closed -$223K 242
2022
Q1
$223K Buy
3,196
+613
+24% +$44.8K 0.05% 268
2021
Q4
$201K Buy
2,583
+323
+14% +$28.5K 0.04% 281
2021
Q3
$216K Buy
2,260
+506
+29% +$53.4K 0.04% 351
2021
Q2
$218K Buy
1,754
+122
+7% +$14.6K 0.05% 301
2021
Q1
$215K Sell
1,632
-2
-0.1% -$274 0.06% 277
2020
Q4
$216K Buy
+1,634
New +$198K 0.07% 208

Other funds holding EXAS

Certuity's EXAS Position: Q3 2023 in Review

Certuity sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 2,685 shares — an estimated $252K sold.

Certuity first reported a position in EXAS in Q4 2020 and held it in 8 quarters. The position peaked at $252K in Q2 2023. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Certuity reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Certuity sold 2,685 Exact Sciences shares in Q3 2023, an estimated $252K.
  • Certuity first reported a position in Exact Sciences in Q4 2020 and held it in 8 quarters.
  • Certuity's Exact Sciences position peaked at $252K in Q2 2023.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Certuity's 13F filing for Q3 2023, filed 3 Nov 2023.